Ademi LLP is investigating Veritiv (NYSE: VRTV) for possible breaches of fiduciary duty and other violations of law in its transaction with CD&R.
In the transaction, Veritiv stockholders are expected to receive only $170 per share. The transaction agreement unreasonably limits competing transactions for Veritiv by imposing a significant penalty if Veritiv accepts a competing bid. Veritiv insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Veritiv’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.